PROTEIN-BINDING OF METHOTREXATE BY THE SERUM OF NORMAL SUBJECTS

被引:41
作者
STEELE, WH [1 ]
LAWRENCE, JR [1 ]
STUART, JFB [1 ]
MCNEILL, CA [1 ]
机构
[1] UNIV GLASGOW, DEPT CLIN ONCOL, GLASGOW G12 8QQ, SCOTLAND
关键词
methotrexate; pharmacokinetics; protein binding; ultrafiltration;
D O I
10.1007/BF00558441
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The protein binding of methotrexate by serum from eight normal volunteers was assessed by continuous ultrafiltration at pH 7.4 and 37°C. Methotrexate concentrations were measured by radioimmunoassay and the data analysed by the method of Scatchard. The major binding protein was albumin which bound 87.3% of the drug in serum. Analysis of the Scatchard plots indicated two distinct groups of binding sites. Class I was found to have 0.16±0.05 (S D) binding sites with an intrinsic association constant of 71.15±35.98 (S D)×104 M-1: Class II had 2.01±0.93 (S D) binding sites and an affinity of 0.18±0.15×104 M-1. No great change in the percentage of methotrexate bound occurred until the total concentration of the drug exceeded 50 μMol 1-1. © 1979 Springer-Verlag.
引用
收藏
页码:363 / 366
页数:4
相关论文
共 27 条
[1]   INTERMITTENT HIGH DOSE ORAL METHOTREXATE THERAPY IN PSORIASIS [J].
BAKER, H .
BRITISH JOURNAL OF DERMATOLOGY, 1970, 82 (01) :65-&
[2]   HIGH-DOSE METHOTREXATE WITH FOLINIC ACID RESCUE [J].
BENDER, JF ;
GROVE, WR ;
FORTNER, CL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (09) :961-965
[3]   MEASUREMENT OF DRUG DISPLACEMENT BY CONTINUOUS ULTRAFILTRATION [J].
CAMPION, DS ;
OLSEN, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (02) :249-252
[4]  
CAPIZZI RL, 1970, CANCER RES, V30, P1782
[5]   CLINICAL PHARMACOLOGY OF ANTINEOPLASTIC AGENTS .2. [J].
CHABNER, BA ;
MYERS, CE ;
COLEMAN, N ;
JOHNS, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (22) :1159-1168
[6]   APPARENT VOLUMES OF DISTRIBUTION AND DRUG BINDING TO PLASMA-PROTEINS AND TISSUES [J].
GIBALDI, M ;
MCNAMARA, PJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 13 (05) :373-378
[7]  
GOTTLIEB JA, 1970, CANCER RES, V30, P2132
[8]  
HENDERSON ES, 1965, CANCER RES, V25, P1008
[9]  
JAFFE N, 1972, CANCER-AM CANCER SOC, V30, P1627, DOI 10.1002/1097-0142(197212)30:6<1627::AID-CNCR2820300631>3.0.CO
[10]  
2-H